News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Evidera Strengthens European Presence With Senior Leader In Health Economics, Outcomes Research And Market Access


7/17/2014 1:51:35 PM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

(Bethesda, MD; July 17, 2014) — Evidera, a global leader in health economics, outcomes research, market access, data analytics and epidemiology solutions, has announced the addition of Xavier Badia, M.D., M.P.H., Ph.D. Badia will serve as senior research leader and senior leader of market development for the growing Evidera team in Europe.

This appointment expands the company’s presence in continental Europe, provides additional local expertise to its current client base and creates opportunities for continued growth. In his role, Badia will provide high-level strategic and scientific leadership in health economics, outcomes research and market access ; offer clients in-depth expertise in European market access and evidence generation; and facilitate communication between Evidera and European decision-making bodies.

With extensive experience in clinical research, working in the public sector and as a consultant for numerous major projects, Badia specializes in evaluating and developing innovative pricing agreements, health policy, clinical effectiveness and patient-reported outcomes. He has led projects focused on therapeutic areas including oncology, endocrinology, cardiovascular, osteoporosis, CNS and rare diseases, among others.

Badia has published more than 180 papers in peer-reviewed journals, six books and several book chapters, and also serves on several editorial boards. He is also an active member of ISPOR, the EuroQol Group, CIBERER and the Spanish Rare Disease Registries Research Network.

“Badia brings a wealth of multidisciplinary knowledge and multifaceted skills to our team,” said Jon Williams, Evidera president and CEO. “His insight and breadth of experience will help us identify areas to add value for our clients in Europe and beyond.”

About Evidera

Evidera, a wholly owned subsidiary of Symphony Technology Group, is one of the preeminent commercial entities analyzing effectiveness, establishing evidence and substantiating the value of treatments within the global health industry through its market-leading portfolio of health economics, outcomes research, market access, data analytics and epidemiology services. Evidera partners with life sciences organizations worldwide to optimize the market access and commercial success of their products by leveraging unparalleled knowledge of the global payer and regulator landscape and by developing, capturing and communicating the clinical and economic evidence that clients require to successfully market their products. Our research and consulting services are driven by world-class science and thought leadership and leverage a unique combination of capabilities. www.evidera.com

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES